Cargando…

Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics

Corneal neovascularization (CoNV) leads to visual impairment, affecting over 1.4 million people in the United States per year. It is caused by a variety of pathologies, such as inflammation, hypoxia, and limbal barrier dysfunction. Injection of the anti-vascular endothelial growth factor (VEGF) drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Wenqi, Sun, Shuo, Tian, Bo, Tai, Phillip W.L., Luo, Yongwen, Ko, Jihye, Zhan, Wei, Ke, Xiao, Zheng, Qiang, Li, Xiaorong, Yan, Hua, Gao, Guangping, Lin, Haijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413663/ https://www.ncbi.nlm.nih.gov/pubmed/34514023 http://dx.doi.org/10.1016/j.omtm.2021.06.007

Ejemplares similares

Low-Dose Recombinant Adeno-Associated Virus-Mediated Inhibition of Vascular Endothelial Growth Factor Can Treat Neovascular Pathologies Without Inducing Retinal Vasculitis
por: Cheng, Shun-Yun, et al.
Publicado: (2021)

Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
por: Lu, Yi, et al.
Publicado: (2018)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

AAV-Genome Population Sequencing of Vectors Packaging CRISPR Components Reveals Design-Influenced Heterogeneity
por: Tran, Ngoc Tam, et al.
Publicado: (2020)

Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction
por: Muhuri, Manish, et al.
Publicado: (2021)

Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022)

rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ
por: Madry, Henning, et al.
Publicado: (2012)

Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG
por: Fuchs, Sebastian P., et al.
Publicado: (2016)

Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model
por: Liu, Huan, et al.
Publicado: (2020)

Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1α
por: Fu, Ying-Cong, et al.
Publicado: (2019)

Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
por: Yang, Yeon-Suk, et al.
Publicado: (2020)

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy
por: Srivastava, Arun
Publicado: (2023)

Corneal neovascularization: An enigma
por: Gupta, Pulkit, et al.
Publicado: (2013)

The use of aflibercept (VEGF trap) in mitigating sulfur mustard-induced corneal neovascularization in a rabbit model
por: Gore, Ariel, et al.
Publicado: (2023)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Multimodal Photoacoustic Imaging‐Guided Regression of Corneal Neovascularization: A Non‐Invasive and Safe Strategy
por: Chu, Chengchao, et al.
Publicado: (2020)

Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver
por: Kleven, Mark D., et al.
Publicado: (2018)

A synthetic AAV vector enables safe and efficient gene transfer to the mammalian inner ear
por: Landegger, Lukas D., et al.
Publicado: (2017)

Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization
por: Schnabolk, Gloriane, et al.
Publicado: (2017)

Corneal neovascularization and biological therapy
por: Voiculescu, OB, et al.
Publicado: (2015)

Therapeutic approaches for corneal neovascularization
por: Feizi, Sepehr, et al.
Publicado: (2017)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Corneal Transduction by Intra-Stromal Injection of AAV Vectors In Vivo in the Mouse and Ex Vivo in Human Explants
por: Hippert, Claire, et al.
Publicado: (2012)

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
por: Alvarez-Rivera, Fernando, et al.
Publicado: (2020)

Adeno-associated Virus Genome Population Sequencing Achieves Full Vector Genome Resolution and Reveals Human-Vector Chimeras
por: Tai, Phillip W.L., et al.
Publicado: (2018)

Assessment of Corneal Angiography Filling Patterns in Corneal Neovascularization
por: Pagano, Luca, et al.
Publicado: (2023)

A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy
por: Dong, Biao, et al.
Publicado: (2013)

Large-scale molecular epidemiological analysis of AAV in a cancer patient population
por: Qin, Wanru, et al.
Publicado: (2021)

Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization
por: Liu, Gaoqin, et al.
Publicado: (2011)

Treating corneal neovascularization using a combination of anti-VEGF injection and argon laser photocoagulation application - case report
por: Donato, Mariela Grossi, et al.
Publicado: (2021)

CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
por: Murlidharan, Giridhar, et al.
Publicado: (2016)

Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis
por: Tai, Felicia, et al.
Publicado: (2020)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

VEGF and Intraocular Neovascularization: From Discovery to Therapy
por: Ferrara, Napoleone
Publicado: (2016)

AAV2-antiVEGFscFv gene therapy for retinal neovascularization
por: Han, Ni, et al.
Publicado: (2023)

Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012)

The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010)

Overcoming the Challenges Imposed by Humoral Immunity to AAV Vectors to Achieve Safe and Efficient Gene Transfer in Seropositive Patients
por: Gross, David-Alexandre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_le2ul29tib3s2qohat4k62unh0